At Home DNA Tests: Marketing Scam or Medical Breakthrough?
July 27, 2006
Statements of Committee Members
Witness Testimony
Gregory D. Kutz, Managing Director, Forensic Audits and Special Investigations, Governmental Accountability Office, Washington, DC
Kathy Hudson, Director, Genetics & Public Policy Center, Johns Hopkins University, Berman Bioethics Institute, Washington, DC
Rosalynn Gill-Garrison, Chief Science Officer, Sciona, Boulder, Colorado
Carol Reed, VP and Chief Medical Officer, Genaissance Pharmaceuticals, Newton, Massachusetts
Kristopher King, CEO, Suracell, Montclair, New Jersey
Rama Rathnam, President, Genox, Baltimore, Maryland
Howard Coleman, CEO, Genelex Corporation, Seattle, Washington
Thomas Hamilton, Director, Survey and Certification Group, Centers for Medicare and Medicaid Services, US Department of Health and Human Services, Washington, DC
Steven M. Gutman, MD, Director, Office of in Vitro Diagnostic Devices, Food and Drug Administration, Washington, DC
Hearing Publications
